- Home
- ARL vs BDTX Comparison
ARL vs BDTX Comparison
Compare ARL & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARL
- BDTX
- Stock Information
- Founded
- ARL 1999
- BDTX 2014
- Country
- ARL United States
- BDTX United States
- Employees
- ARL N/A
- BDTX N/A
- Industry
- ARL Building operators
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARL Real Estate
- BDTX Health Care
- Exchange
- ARL Nasdaq
- BDTX Nasdaq
- Market Cap
- ARL 205.1M
- BDTX 181.4M
- IPO Year
- ARL N/A
- BDTX 2020
- Fundamental
- Price
- ARL $15.21
- BDTX $2.75
- Analyst Decision
- ARL
- BDTX Strong Buy
- Analyst Count
- ARL 0
- BDTX 5
- Target Price
- ARL N/A
- BDTX $13.40
- AVG Volume (30 Days)
- ARL 2.6K
- BDTX 854.1K
- Earning Date
- ARL 08-07-2025
- BDTX 08-07-2025
- Dividend Yield
- ARL N/A
- BDTX N/A
- EPS Growth
- ARL N/A
- BDTX N/A
- EPS
- ARL N/A
- BDTX 0.25
- Revenue
- ARL $48,139,000.00
- BDTX $70,000,000.00
- Revenue This Year
- ARL N/A
- BDTX N/A
- Revenue Next Year
- ARL N/A
- BDTX N/A
- P/E Ratio
- ARL N/A
- BDTX $10.91
- Revenue Growth
- ARL N/A
- BDTX N/A
- 52 Week Low
- ARL $9.43
- BDTX $1.20
- 52 Week High
- ARL $19.68
- BDTX $6.37
- Technical
- Relative Strength Index (RSI)
- ARL 62.42
- BDTX 50.12
- Support Level
- ARL $14.43
- BDTX $2.56
- Resistance Level
- ARL $15.63
- BDTX $2.98
- Average True Range (ATR)
- ARL 0.38
- BDTX 0.16
- MACD
- ARL 0.16
- BDTX 0.01
- Stochastic Oscillator
- ARL 85.95
- BDTX 57.83
About ARL American Realty Investors Inc.
American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.